[1] IAFRATE M, ERMACORA C, MORLACCO A, et al. Metabolic syndrome and andrological diseases[J]. Panminerva Med,2022, 64(3):324-328. [2] BELLADELLI F, MONTORSI F, MARTINI A. Metabolic syndrome, obesity and cancer risk[J].Curr Opin Urol,2022,32(6):594-597. [3] GIAMPÁ S Q C, FURLAN S F, FREITAS L S, et al. Effects of CPAP on Metabolic Syndrome in Patients With OSA: A Randomized Trial[J].Chest,2022, 161(5):1370-1381. [4] LITWIN M, KUĆAGA Z. Obesity, metabolic syndrome, and primary hypertension[J].Pediatr Nephrol,2021, 36(4):825-837. [5] HERMOSO D A M, BIZERRA P F V, CONSTANTIN R P, et al. Association between metabolic syndrome, hepatic steatosis, and testosterone deficiency: evidences from studies with men and rodents[J].Aging Male,2020, 23(5):1296-1315. [6] YANG C, LIU X W, LI J, et al. Association of serum vitamin d and estradiol levels with metabolic syndrome in rural women of northwest china: a cross-sectional study[J].Metab Syndr Relat Disord,2022, 20(3):182-189. [7] 黄洁武, 吴东亭, 宋嘉宜, 等. 甲状腺正常人群脂质蓄积指数、内脏脂肪指数与代谢综合征患病关系[J].中国公共卫生, 2022, 38(9):1181-1186. [8] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J].中华糖尿病杂志, 2021, 13(4):315-409. [9] BRIL F, SANYAL A, CUSI K. Metabolic syndrome and its association with nonalcoholic steatohepatitis[J].Clin Liver Dis,2023, 27(2):187-210. [10] FÜHRER D, REINCKE M. Dyslipidemia and metabolic syndrome[J].Inn Med (Heidelb),2023, 64(7):609-610. [11] 李浙成, 胡智星, 童跃峰, 等. 超声测量的内脏脂肪厚度和代谢综合征的关系[J].中华高血压杂志, 2006, 14(11):874-878. [12] 段绍杰, 刘尊敬, 陈佳良, 等. 脂质蓄积指数和内脏脂肪指数对成年人代谢综合征的预测价值研究[J].中国全科医学, 2021, 24(33):4211-4217. [13] 郭兴梁, 刘芙蓉. 老年代谢综合征患者预后情况与血清钙、游离脂肪酸水平的相关性分析[J].公共卫生与预防医学, 2022, 33(6):98-101. [14] KATAHIRA M, MORIURA S, ONO S. Estimation of visceral fat area using criteria for metabolic syndrome: a cross-sectional study[J].Diabetes Metab Syndr,2022,16(8):102584-102587. [15] YEAP B B. Rates of conversion of testosterone to estradiol may influence risk of venous thromboembolism in men[J].J Clin Endocrinol Metab,2021, 106(8):3275-3277.